GlassScriptPhysician profile
Tima Peterson
NPI 1992281414
$2,811.61
in general payments reported to CMS, 2019-2025
38 companies · $1,975 in 2025
The $1,975 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2024: $729 · 2025: $1,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,627 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,626.57 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $297.71 | 2024-2025 | Reblozyl, Opdivo, Opdualag |
| Astrazeneca Pharmaceuticals LP | $238.21 | 2024-2025 | Imfinzi, Enhertu, Tagrisso |
| Merck Sharp & Dohme LLC | $192.06 | 2024-2025 | Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $165.59 | 2024-2025 | |
| Eisai INC. | $125.53 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $121.78 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $120.66 | 2025 | |
| Janssen Biotech, INC. | $112.91 | 2024-2025 | Rybrevant, Erleada |
| Glaxosmithkline, LLC. | $108.38 | 2024-2025 | Ojjaara, Jemperli |
| Nestle Healthcare Nutrition INC. | $107.05 | 2021 | |
| Alexion Pharmaceuticals, INC. | $92.10 | 2024-2025 | Ultomiris |
| Incyte Corporation | $82.42 | 2025 | Monjuvi, Zynyz |
| Lilly USA, LLC | $80.93 | 2024-2025 | Verzenio, Jaypirca, Retevmo |
| Seagen INC. | $77.99 | 2025 | |
| Pfizer INC. | $77.26 | 2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tima Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.